Leave Your Message
ADT1027-Amatuximab Biosimilar– Anti-MSLN mAb – Research Grade
Hot

ADT1027-Amatuximab Biosimilar– Anti-MSLN mAb – Research Grade

  • Catalog Number ADT1027
  • Host CHO Cells
  • Species Human
  • Target MSLN/Mesothelin
  • Application Functional assay, IF, Neut, ELISA, FC, IP, ICC

MSLN (Mesothelin) is a Protein Coding gene. Diseases associated with MSLN include Benign Mesothelioma and Malignant Pleural Mesothelioma. Among its related pathways are Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) and Metabolism of proteins. An important paralog of this gene is MSLNL.Membrane-anchored forms may play a role in cellular adhesion.Megakaryocyte-potentiating factor (MPF) potentiates megakaryocyte colony formation in vitro.

Whether for early-stage research or large-scale production, Alpha Lifetech delivers tailored solutions to meet your exact needs, offering unmatched flexibility and high performance in every batch.

Products Categories
Featured Products
recommended service
quick links
Contact Us

Product Background

Mesothelin (MSLN) is a glycoprotein proteolytic protein by the Pre-pro-MSLN precursor, containing N-terminal signal peptide, mature megakaryocytic enhancement factor (MPF), furan cleavage sites, mature MSLN and GPI anchor sequences. The extracellular domain of MSLN contains multiple Ig-like domains and GPI anchor domains involved in intercellular interactions and signaling through binding with other proteins.

Product Specification

Catalog Number

ADT1027

Product Name

ADT1027-Amatuximab Biosimilar– Anti-MSLN mAb – Research Grade

Alias

MORAb-009

Isotype

IgG1 Kappa

Clonity

Monoclonal

Alternate Names

human mesothelin, anti-MSLN mAb, anti-MSLN antibody, MSLN monoclonal antibody, mesothelin monoclonal antibody

Official Symbol

MSLN/Mesothelin

Species

Human

Expression Host

CHO Cells

Reactivity

Human

Gene ID

10232

CAS Number

931402-35-6

Product Description

Amatuximab has been used in trials studying the treatment and basic science of Mesothelioma, Ovarian Cancer, Ovarian Neoplasms, Pancreatic Cancer, and Mesothelioma, Malignant, among others.

Mechanism of Action

Amatuximab is a monoclonal antibody that targets the glycoprotein 2 (gp2) antigen, which is often expressed on the surface of cancer cells.

Metabolism

As a full-length monoclonal antibody, Amatuximab has a long half-life, allowing for extended therapeutic activity. Its pharmacokinetics involve distribution into the bloodstream and various tissues.

Size

100ug,1mg,5mg

Research Area

Cancer

Application

Functional assay, IF, Neut, ELISA, FC, IP, ICC

Purity

>95% as determined by SDS-PAGE

Concentration

Batch dependent

Buffer

Supplied in PBS, PH7.5

Storage

Store at -20 °C for 12 months. Store at -80 °C for long term storage.

Shipping Condition

Shipped on ice packs.

Note

This product is for research use only. 

Reference

1.Weidemann S, et al. Cancer Invest, 2021 Oct. PMID 34143695
2.Yang P, et al. Cell Immunol, 2021 Feb. PMID 33373818
3.Liu X, et al. Commun Biol, 2020 Dec 1. PMID 33262421

 

FAQ

Leave Your Message